In this process, royalty recipients often face the issue where multiple small future royalty streams cannot fulfill ongoing large lump-sum R&D funding needs. The mismatch is where Royalty Pharma ...

Given that the current U.S. administration purports to abhor trade deficits, European exporters are firmly in the line of ...

Ivison noted the most egregious example in the report – the case of the Canadian Research Chair in Quantum Sensors for Space ...